CEPHALON FINLAND A/S: Financial statements 2022
CVR: 29245037
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
CEPHALON FINLAND A/S (CVR 29245037) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 6,993,435 and a net result of DKK 2,153,940 compared with DKK 1,333,536 the year before. That is an increase of 21.2% compared with the year before. Equity in the 2022 report amounted to DKK 6,866,373. The solvency ratio was 66.9%. The company had 5 employees in the financial year.
- Gross Profit
- DKK 6,993,435
- Profit/Loss
- DKK 2,153,940
- Equity
- DKK 6,866,373
- Total Assets
- DKK 10,260,808
- Employees
- 5
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 7M | 2.2M | 6.9M | 5 |
| 2021 | - | 5.8M | 1.3M | 6M | 6 |
| 2020 | - | 4.4M | 973K | 5.6M | 5 |
| 2019 | - | 3.8M | 720K | 5.3M | 3 |
| 2018 | - | 3.2M | 267K | 4.8M | 3 |
Official annual report
Keep an eye on CEPHALON FINLAND A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
CEPHALON FINLAND A/S has published its annual report for 2021. Gross profit came to DKK 5,772,257, and the net result was DKK 1,333,536.
As of May 3, 2022, RéVision+ Statsautoriseret Revisionsanpartsselskab has been appointed auditor of CEPHALON FINLAND A/S.
As of May 3, 2022, RéVision+ Ejendomme ApS has stepped down as auditor of CEPHALON FINLAND A/S.
About CEPHALON FINLAND A/S
CEPHALON FINLAND A/S is a Danish company of the type Aktieselskab based in Nørresundby, founded in 2006. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The management consists of Rolf Nejsum. The board consists of Bjørn Helmer Johnsen (chair), Rolf Nejsum and Vesa Antero Toropainen. The company is owned by Scanmed AS Norway. The company has 0 employees (2017). In 2025, the company reported a gross profit of DKK 7,078,554 and a net result of DKK 2,059,375 compared with DKK 296,806 the year before. Equity in the 2025 report amounted to DKK 7,193,391.
